脑积水增长:急性脑出血中的定义、患病率及与不良预后的关联
该研究纳入2011年7月至2017年6月期间发病6小时内就诊的321例连续脑出血患者,在初诊CT后36小时内复查CT,采用Diringer脑积水评分评估脑积水程度,并估算定义脑积水增长的最佳评分增加阈值。多因素logistic回归显示脑积水增长独立预测30天死亡、90天死亡和90天不良预后(mRS 4-6),且预测准确性分别高于脑室出血增长或血肿扩大。
要点
- 在发病6小时内就诊的脑出血患者中,脑积水增长(Diringer评分较初诊CT增加)独立预测30天死亡、90天死亡和90天不良预后(mRS 4-6)。
- 脑积水增长对30天死亡、90天死亡和90天不良预后的预测准确性分别高于脑室出血增长或血肿扩大。
- 建议对急性脑出血患者初诊CT后36小时内复查CT,动态评估脑积水评分变化。
适用人群与场景
- 发病6小时内就诊的连续脑出血患者(2011年7月至2017年6月纳入)。
- 排除标准及具体纳入人群特征原文未提及。
- 场景为急诊/住院初期,需在初诊CT后36小时内完成复查CT。
诊断标准与关键阈值
- 脑积水程度采用Diringer脑积水评分评估。
- 脑积水增长定义为初诊与复查CT之间脑积水评分的最佳增加阈值(原文未给出具体界值)。
- 不良长期预后定义为3个月时改良Rankin量表(mRS)评分4-6分。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 脑积水增长提示30天死亡、90天死亡和90天不良预后风险升高,需加强监测与临床决策。
- 脑积水增长常合并血肿扩大和脑室出血增长(64例中34例,53.1%),需同时评估这些情况。
研究设计与关键结果
- 研究类型为回顾性队列分析,纳入321例发病6小时内就诊的脑出血患者,单中心(原文未明确中心数)。
- 多因素logistic回归显示脑积水增长独立预测30天死亡、90天死亡和90天不良预后(mRS 4-6)。
- 脑积水增长对30天死亡、90天死亡和90天不良预后的预测准确性分别高于脑室出血增长或血肿扩大。
证据类型、等级与局限
- 证据类型为回顾性队列研究(连续病例分析),原文未给出证据等级或推荐强度。
- 局限性:单中心、回顾性设计、样本量321例,脑积水增长的定义阈值需进一步验证;原文未提及盲法或外部验证。
对床旁实践的改变
- 对发病6小时内的脑出血患者,应在初诊CT后36小时内复查CT并动态评估Diringer脑积水评分,识别脑积水增长。
- 脑积水增长可作为临床决策的潜在指标,提示短期和长期死亡及不良预后风险升高,需加强监护和评估。
- 脑积水增长常与血肿扩大和脑室出血增长并存,评估时需同时关注这些改变。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND/OBJECTIVES: To propose a novel definition for hydrocephalus growth and to further describe the association between hydrocephalus growth and poor outcome among patients with intracerebral hemorrhage (ICH).
METHODS: We analyzed consecutive patients who presented within 6 h after ICH ictus between July 2011 and June 2017. Follow-up CT scans were performed within 36 h after initial CT scans. The degree of hydrocephalus were evaluated by the hydrocephalus score of Diringer et al. The optimal increase of the hydrocephalus scores between initial and follow-up CT scan was estimated to define hydrocephalus growth. Poor long-term outcome was defined as a modified Rankin Scale of 4-6 at 3 months. Multivariate logistic regression analysis was performed to investigate the hydrocephalus growth for predicting 30-day mortality, 90-day mortality, and poor long-term outcome.
RESULTS: A total of 321 patients with ICH were included in the study. Of 64 patients with hydrocephalus growth, 34 (53.1%) patients presented with both concurrent hematoma expansion and intraventricular hemorrhage (IVH) growth. After adjusting for potential confounding factors, hydrocephalus growth independently predicted 30-day mortality, 90-day mortality, and 90-day poor long-term outcome in multivariate logistic regression analysis. Hydrocephalus growth showed higher accuracy for predicting 30-day mortality, 90-day mortality, and poor long-term outcome than IVH growth or hematoma expansion, respectively.
CONCLUSIONS: Hydrocephalus growth is defined by strongly predictive of short- or long-term mortality and poor outcome at 90 days, and might be a potential indicator for assisting clinicians for clinical decision-making.
参考来源
- Yang WS, Shen YQ, Zhang XD, et al. Hydrocephalus Growth: Definition, Prevalence, Association with Poor Outcome in Acute Intracerebral Hemorrhage. Neurocrit Care. 2020. PMID: 33174150. doi:10.1007/s12028-020-01140-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。